Effectiveness of lurasidone in adolescents with schizophrenia: interim analysis of a 24-month, open-label extension study

被引：1
|
作者：
Tocco, M. [1 ]
Arango, C. [2 ]
Correll, C. U. [3 ]
Goldman, R. [4 ]
Cucchiaro, J. [5 ]
Deng, L. [6 ]
Loebel, A. [7 ]
机构：
[1] Sunov Pharmaceut Inc, Marlborough, MA USA
[2] Univ Complutense, Hosp Gen Univ Gregorio Maranon, Serv Psiquiatria Nino & Adolescente, CIBERSAM,IiSGM,Fac Med, Madrid, Spain
[3] Hofstra North Shore LIJ Sch Med, Dept Psychiat & Mol Med, Hempstead, NY USA
[4] Sunov Pharmaceut Inc, Clin Dev & Med Affairs, Marlborough, MA USA
[5] Sunov Pharmaceut Inc, Clin Dev, Ft Lee, NJ USA
[6] Sunov Pharmaceut Inc, Biostat, Ft Lee, NJ USA
[7] Sunov Pharmaceut Inc, Clin Dev & Med Affairs, Ft Lee, NJ USA
来源：
EUROPEAN NEUROPSYCHOPHARMACOLOGY | 2017年 / 27卷
关键词：
D O I：
10.1016/S0924-977X(17)31911-9
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P.7.b.015
引用
收藏
页码：S1100 / S1101
页数：2
相关论文
共 50 条
  • [21] Safety and effectiveness of lurasidone in adolescents with schizophrenia: results of a 2-year, open-label extension study (pg 1, 2020)
    Correll, Christoph U.
    Findling, Robert L.
    Tocco, Michael
    Pikalov, Andrei
    Deng, Ling
    Goldman, Robert
    CNS SPECTRUMS, 2022, 27 (01) : 129 - 129
  • [22] Efficacy and safety of lurasidone in adolescents with schizophrenia: Results of a 2-year, open-label extension study
    Goldman, R.
    Correll, C.
    Tocco, M.
    Pikalov, A.
    Deng, L.
    Loebel, A.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2019, 29 : S88 - S89
  • [23] EFFICACY AND SAFETY OF LURASIDONE IN ADOLESCENTS WITH SCHIZOPHRENIA: RESULTS OF A TWO-YEAR OPEN-LABEL EXTENSION STUDY
    Goldman, Robert S.
    Tocco, Michael
    Pikalov, Andrei A.
    Deng, Ling
    Loebel, Antony
    JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2018, 57 (10): : S160 - S160
  • [24] Safety and effectiveness of long-term treatment with lurasidone in children and adolescents with bipolar depression: A 6-month interim analysis of a 2-year open-label extension study
    Chang, K.
    Tocco, M.
    Goldman, R.
    Pikalov, A.
    Deng, L.
    Cucchiaro, J.
    Loebel, A.
    EUROPEAN PSYCHIATRY, 2018, 48 : S81 - S82
  • [25] Effect of lurasidone on cognition in children and adolescents with bipolar depression: Interim analysis of a 2-year open-label extension study
    Burdick, K. E.
    Goldman, R.
    Tocco, M.
    Deng, L.
    Loebel, A.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2019, 29 : S367 - S368
  • [26] EFFICACY AND SAFETY OF LURASIDONE IN CHILDREN AND ADOLESCENTS WITH BIPOLAR DEPRESSION: INTERIM ANALYSIS OF A TWO-YEAR OPEN-LABEL EXTENSION STUDY
    Goldman, Robert S.
    DelBello, Melissa P.
    Tocco, Michael
    Pikalov, Andrei A.
    Deng, Ling
    Loebel, Antony
    JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2018, 57 (10): : S137 - S137
  • [27] Lurasidone in bipolar I depression: a 24 week, open-label extension study
    Ketter, T. A.
    Sarma, K.
    Silva, R.
    Kroger, H.
    Cucchiaro, J.
    Loebel, A.
    Grossman, F.
    Pikalov, A.
    BIPOLAR DISORDERS, 2014, 16 : 131 - 131
  • [28] Lurasidone in Bipolar I Depression: A 24 Week, Open-label Extension Study
    Ketter, Terence
    Sarma, Kaushik
    Silva, Robert
    Xu, Jane
    Cucchiaro, Josephine
    Loebel, Antony
    NEUROPSYCHOPHARMACOLOGY, 2013, 38 : S534 - S535
  • [29] Lurasidone in bipolar I depression: a 24 week, open-label extension study
    Ketter, T.
    Pikalov, A.
    Sarma, K.
    Silva, R.
    Kroger, H.
    Cucchiaro, J.
    Loebel, A.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2014, 24 : S443 - S444
  • [30] Global Open-label Extension: 24-month Data of Patisiran in Patients with hATTR Amyloidosis
    Adams, David
    Gonzalez-Duarte, Alejandra
    Mauricio, Elizabeth
    Brannagan, Thomas
    Coelho, Teresa
    Wixner, Jonas
    Schmidt, Hartmut
    Berber, Erhan
    Sweetser, Marianne
    White, Matthew
    Wang, Jing Jing
    Polydefkis, Michael
    JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2020, 25 (04) : 524 - 525
12345